share_log

Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target

Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target

Canaccord Genuity 重申買入KORU Medical Systems,維持3美元的目標股價
Benzinga ·  2023/12/07 10:36

Canaccord Genuity analyst Caitlin Cronin reiterates KORU Medical Systems (NASDAQ:KRMD) with a Buy and maintains $3 price target.

Canaccord Genuity分析師凱特琳·克羅寧重申了KORU Medical Systems(納斯達克股票代碼:KRMD)的買入並維持3美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論